About this episode
美国制药巨头默沙东和生物技术公司莫德纳合作的个性化mRNA癌症疫苗intismeran autogene，在大型III期临床试验中取得初步阳性结果。个性化 mRNA 癌症疫苗从“概念”走向“临床验证”，迫使产业链价值重估——基因测序从“诊断工具”跃升为“制药起点”，是“一人一药”范式不可绕过的第一道工序。
Get every episode summarized
Each time 天方烨谈 publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
